NASDAQ · Drug Manufacturers - Specialty & Generic

InMed Pharmaceuticals Inc (INM)

$1.60 -1.54%
Add alert See all overbought stocks →
71 Overbought Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$1.18+35.59%

Company profile

InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$7.47M
P/E ratioNone
EPS$-2.84
Beta0.928
Dividend yield0.00%
52-week high$2.33
52-week low$0.58

Similar stocks in Drug Manufacturers - Specialty & Generic

HIMS Hims & Hers Health Inc - Class A RSI 45 CGC Canopy Growth Corporation RSI 25 BFRI Biofrontera Inc RSI 42 TLRY Tilray Brands Inc - Class 2 RSI 18 ORGO Organogenesis Holdings Inc - Class A RSI 16 ACB Aurora Cannabis Inc RSI 50 BCRX Biocryst Pharmaceuticals Inc RSI 55 LNTH Lantheus Holdings Inc RSI 56
30 days of PRO Unlimited free, no card

RSI alerts for INM

An email when INM closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 10:33 PM EDT